Nobel Prize Recognizes Pioneering Body's Defenses Discoveries

The prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the immune system attacks harmful pathogens while protecting the healthy tissues.

Three renowned researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this honor.

Their research identified unique "sentinels" within the immune system that remove malfunctioning immune cells that could attacking the organism.

These findings are now enabling innovative treatments for autoimmune diseases and malignancies.

These winners will share a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The research has been essential for understanding how the immune system operates and the reason we do not all develop serious autoimmune diseases," stated the head of the award panel.

This team's studies address a fundamental question: How does the defense system protect us from countless infections while leaving our healthy cells intact?

Our body's protection system employs immune cells that search for signs of infection, even viruses and germs it has never encountered.

These cells utilize sensors—known as receptors—that are produced by chance in countless variations.

This provides the immune system the capacity to fight a wide array of threats, but the randomness of the mechanism unavoidably produces white blood cells that can target the host.

Protectors of the Immune System

Scientists earlier knew that some of these problematic defense cells were destroyed in the immune organ—the site where white blood cells mature.

This year's Nobel Prize honors the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These discoveries have laid the foundation for a novel area of research and accelerated the development of new treatments, for example for tumors and autoimmune diseases."

In malignancies, regulatory T-cells prevent the system from attacking the growth, so research are focused on lowering their numbers.

For self-attack disorders, trials are exploring boosting T-reg cells so the organism is not under attack. A similar method could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland extracted, leading to self-attack conditions.

The researcher showed that injecting defense cells from healthy animals could stop the disease—implying there was a mechanism for blocking defenders from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic autoimmune disease in mice and humans that resulted in the identification of a gene vital for the way regulatory T-cells function.

"Their pioneering work has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"This work is a striking illustration of how basic biological study can have far-reaching implications for public health."